Todays Report: The athenahealth Inc. (ATHN) Upgraded at Evercore ISI

The athenahealth Inc. (ATHN) Upgraded at Evercore ISI

Evercore ISI upgraded shares of athenahealth Inc. (NASDAQ:ATHN) from a hold rating to a buy rating in a research note issued to investors on Monday morning. They currently have $152.00 price objective on the stock.

Other research analysts have also issued reports about the company. Deutsche Bank AG lowered athenahealth from a buy rating to a hold rating and dropped their target price for the stock from $165.00 to $147.00 in a research report on Friday, July 22nd. Jefferies Group reaffirmed an underperform rating and issued a $105.00 target price on shares of athenahealth in a research report on Monday, July 25th. Zacks Investment Research raised athenahealth from a sell rating to a hold rating in a research report on Thursday, August 4th. Morgan Stanley dropped their target price on athenahealth from $186.00 to $153.00 and set an overweight rating on the stock in a research report on Monday, July 25th. Finally, Canaccord Genuity reaffirmed a hold rating and issued a $142.00 target price on shares of athenahealth in a research report on Wednesday, June 29th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $149.70.

Shares of athenahealth (NASDAQ:ATHN) opened at 127.30 on Monday. athenahealth has a one year low of $114.59 and a one year high of $170.42. The stock has a market cap of $5.01 billion, a PE ratio of 468.01 and a beta of 1.28. The stock’s 50 day moving average price is $123.62 and its 200-day moving average price is $129.75.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, July 21st. The company reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by $0.08. The business earned $261.90 million during the quarter, compared to analysts’ expectations of $274.07 million. athenahealth had a return on equity of 5.16% and a net margin of 1.06%. On average, equities analysts predict that athenahealth will post $1.77 earnings per share for the current fiscal year.

In other athenahealth news, Director Brandon H. Hull sold 2,400 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $130.00, for a total value of $312,000.00. Following the completion of the sale, the director now owns 3,987 shares in the company, valued at approximately $518,310. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Karl Stubelis sold 928 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $123.36, for a total value of $114,478.08. Following the completion of the sale, the vice president now owns 1,375 shares of the company’s stock, valued at approximately $169,620. The disclosure for this sale can be found here. 3.04% of the stock is owned by company insiders.

Hedge funds have recently made changes to their positions in the company. Daiwa SB Investments Ltd. purchased a new stake in shares of athenahealth during the third quarter worth approximately $1,009,000. Public Employees Retirement System of Ohio increased its stake in shares of athenahealth by 1.9% in the second quarter. Public Employees Retirement System of Ohio now owns 14,737 shares of the company’s stock worth $2,034,000 after buying an additional 274 shares in the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of athenahealth by 5.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 122,658 shares of the company’s stock worth $16,929,000 after buying an additional 5,999 shares in the last quarter. Amalgamated Bank increased its stake in shares of athenahealth by 36.3% in the second quarter. Amalgamated Bank now owns 6,216 shares of the company’s stock worth $777,000 after buying an additional 1,655 shares in the last quarter. Finally, Legal & General Group Plc increased its stake in shares of athenahealth by 21.4% in the second quarter. Legal & General Group Plc now owns 3,379 shares of the company’s stock worth $466,000 after buying an additional 596 shares in the last quarter.

athenahealth Company Profile

Related posts

Leave a Comment